Biologics


Biotech companies face unique challenges as they move from research and clinical development to commercial manufacturing. RCA helps organizations establish scalable quality systems, prepare for regulatory inspections, optimize manufacturing operations, and maintain compliance throughout every stage of growth.

Regulatory & Quality Consulting for Emerging and Commercial Biotech Companies

Biotechnology companies operate in an environment where scientific innovation, accelerated development timelines, and regulatory compliance must remain closely aligned. As organizations scale operations from clinical development to commercial manufacturing, strong quality systems and operational controls become critical to long-term success.

RCA supports biotech organizations with strategic and hands-on consulting services designed to strengthen regulatory compliance, improve manufacturing readiness, and support operational growth.

From early-stage biotech startups to commercial biologics manufacturers, RCA provides scalable expertise to help organizations navigate evolving FDA expectations and complex manufacturing environments.

Why Biotech Companies Partner with RCA

Deep biologics and advanced therapy expertise
Former FDA and industry professionals
Cross-functional regulatory and technical support
Practical remediation experience
Scalable consulting resources
Global compliance expertise

Frequently Asked Questions

What regulatory and quality consulting services do biotech companies need?

Biotechnology companies may need support with regulatory strategy, quality system development, manufacturing readiness, validation, inspection preparation, and compliance remediation as they advance from research and clinical development to commercialization. The specific needs depend on the product, development stage, and manufacturing model. RCA supports emerging and established biotech organizations with regulatory, quality, and technical consulting tailored to their operational and compliance challenges.

What cGMP requirements apply to biologics manufacturing?

Biologics manufacturers must comply with applicable FDA requirements for manufacturing quality, process controls, documentation, facilities, and product testing. Depending on the product and activities, relevant requirements can include biologics regulations under 21 CFR Parts 600 through 680 and applicable drug cGMP requirements under Parts 210 and 211. RCA helps biotech companies assess regulatory gaps, strengthen quality systems, and support manufacturing compliance.

How can biotech companies prepare for an FDA inspection?

Biotech companies can prepare by reviewing quality system documentation, evaluating deviations and CAPAs, assessing data integrity, verifying manufacturing and validation records, and training employees on inspection procedures. Companies approaching commercialization may also need to assess readiness for a pre-approval inspection. RCA provides inspection readiness, mock audit, gap assessment, and remediation support tailored to biotech and biologics operations.

How can a biotech startup establish a quality management system before commercialization?

A biotech startup should develop a quality management system appropriate to its products, activities, development stage, and applicable regulations. Important elements may include document control, training, change management, deviation investigations, CAPA, supplier oversight, and risk management. RCA helps biotech organizations evaluate quality system needs, establish scalable processes, and prepare for future manufacturing and regulatory milestones.

How can biotech companies address FDA compliance gaps or quality system deficiencies?

Biotech companies should determine the root causes and scope of deficiencies, prioritize risks to product quality and patient safety, and develop documented corrective and preventive actions. Remediation may involve quality system improvements, manufacturing controls, validation, documentation, and employee training. RCA provides compliance assessments, remediation planning, and hands-on quality support to help organizations address issues and build sustainable systems.

Related Content

Case Studies

Biosimilar Drug Development

Client Challenge A European based company engaged in biosimilar drug development requested RCA to develop a regulatory strategy for seeking approval for their drug in the US and EU. The...
Read More

Visual Resources

Biologics Info Sheet

Whether you need support with Product Development, Formulation Development, Compliance Assurance, Clinical and Manufacturing Development, Guidance and Pathways for Biologic/Biosimilar Approval, FDA Briefing, or Application Submission, RCA. can help. Download...
Read More

Case Studies

Biologics Manufacturing: Design & Build Out

Background A biological drug development company based in Europe came to RCA as their facility expansion was under construction. A team of RCA experts engaged in guiding this company through...
Read More

Connect with RCA Today

Contact us to learn more about our regulatory compliance experts and how they can help

    Footer artwork